Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists

Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists

Purpose of review: Use of gadolinium-based contrast agents (GBCA) in renal impairment is controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic kidney disease (CKD), and dialysis because of concerns regarding nephrogenic systemic fibrosis (NSF). The position tha...

Full description

Bibliographic Details
Main Authors: Nicola Schieda, Jason I. Blaichman, Andreu F. Costa, Rafael Glikstein, Casey Hurrell, Matthew James, Pejman Jabehdar Maralani, Wael Shabana, An Tang, Anne Tsampalieros, Christian B. van der Pol, Swapnil Hiremath
Format: Article
Language:English
Published: SAGE Publishing 2018-06-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1177/2054358118778573

Internet

https://doi.org/10.1177/2054358118778573

Similar Items